US Drug Recall Register

Is Chloride recalled?

Yes — there is an active recall. 326 ongoing FDA recalls mention Chloride (1,994 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Chloride. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed.

Class II · Moderate risk Terminated

Sodium Chloride 0.9% Injection

Reason CGMP Deviation: Chemical indicators were not positioned properly during sterilization process.

Fresenius Medical Care Holdings, Inc. D-1064-2020
Class III · Low risk Terminated

CVS Health Sodium Chloride Ophthalmic Ointment USP

Reason Presence of Particulate Matter: Brown spots observed on the inside of the tube of product, identified as tin with trace copper, which are the base of the materials of construction for the tube.

Akorn, Inc. NDC 59779-303-01 D-0861-2020
Class III · Low risk Terminated

Well at Walgreens Sodium Chloride Ophthalmic Ointment USP

Reason Presence of Particulate Matter: Brown spots observed on the inside of the tube of product, identified as tin with trace copper, which are the base of the materials of construction for the tube.

Akorn, Inc. NDC 0363-9050-00 D-0860-2020
Class III · Low risk Terminated

Sodium Chloride Ophthalmic Ointment USP

Reason Presence of Particulate Matter: Brown spots observed on the inside of the tube of product, identified as tin with trace copper, which are the base of the materials of construction for the tube.

Akorn, Inc. NDC 17478-622-35 D-0859-2020
Class III · Low risk Terminated

Potassium Chloride Extended-Release Tablets USP

Reason Failed Tablet/Capsules Specifications: Oversized tablets were found in one lot of Potassium Chloride Tablets 750 mg.

Strides Pharma Science Limited NDC 64380-861-08 D-1029-2020
Class III · Low risk Terminated

Discount Drug Mart

Reason Labeling: Incorrect or Missing Lot and/or Expiration date.

AAA Pharmaceutical, Inc. NDC 53943-192-04 D-0868-2020
Class III · Low risk Terminated

TRAMADOL HYDROCHLORIDE Tablets

Reason Labeling: Incorrect package insert - Patient leaflets for the specified lots of unscored tablets contain language relative to a 25 mg dosing titration that necessitates the use of a scored 50 mg tablet.

Golden State Medical Supply Inc. NDC 60429-588-01 D-0856-2020
Class II · Moderate risk Terminated

Memantine Hydrochloride Extended Release Capsules

Reason Failed Dissolution Specifications: Low out of specification results observed in dissolution test at six-month long-term stability study.

Lupin Pharmaceuticals Inc. NDC 68180-248-06 D-0855-2020
Class III · Low risk Terminated

Clonidine Hydrochloride Tablets

Reason Failed Impurities/Degredation Specifications: This recall is initiated as a precautionary measure due to potential migration of Benzophenone at very low level into product from container label.

Unichem Pharmaceuticals USA INC NDC 29300-135-01 D-0829-2020
Class III · Low risk Terminated

Tramadol Hydrochloride Tablets USP CIV

Reason Labeling: Incorrect package insert - Patient leaflets for the specified lots of unscored tablets contain language relative to a 25 mg dosing titration that necessitates the use of a scored 50 mg tablet.

Teva Pharmaceuticals USA NDC 0093-0058-01 D-0851-2020
Class III · Low risk Terminated

Pioglitazone and Metformin Hydrochloride Tablets

Reason Subpotent Drug: Out of specification assay result, below specification, for two lots of Pioglitazone And Metformin Hydrochloride Tablets.

Macleods Pharma Usa Inc D-0838-2020
Class III · Low risk Terminated

Minocycline Hydrochloride Extended-Release Tablets

Reason Failed Dissolution Specifications: low out of specification results for dissolution testing.

Ascend Laboratories LLC NDC 67877-438-30 D-0827-2020
Class II · Moderate risk Terminated

Zinc Chloride Injection

Reason Lack of Assurance of Sterility

Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0224-3 D-0994-2020
Class II · Moderate risk Terminated

Pyridoxine Hydrochloride Injection

Reason Lack of Assurance of Sterility

Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0216-3 D-0980-2020
Class III · Low risk Terminated

Magnesium Chloride Injection

Reason Lack of Assurance of Sterility

Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0225-5 D-0964-2020
Class II · Moderate risk Terminated

Lysine Hydrochloride Injection

Reason Lack of Assurance of Sterility

Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0342-3 D-0963-2020
Class II · Moderate risk Terminated

Arginine Hydrochloride Injection

Reason Lack of Assurance of Sterility

Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0341-3 D-0959-2020
Class II · Moderate risk Terminated

Calcium Chloride Injection

Reason Lack of Assurance of Sterility

Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0225-3 D-0946-2020